Exciting Updates from BrainsWay
BURLINGTON and JERUSALEM — BrainsWay Ltd. (NASDAQ: BWAY) is ready to share its third-quarter financial results, highlighting its innovative advancements in noninvasive neurostimulation treatments aimed at mental health disorders. This event is scheduled for a date in November when the U.S. markets open. The dedicated team at BrainsWay will also provide operational insights during this session.
Conference Call Details
Join the Conversation
The third-quarter conference call is set for 8:30 AM Eastern Time, where the management will present the financial outcomes and discuss future strategies. This is an excellent opportunity for investors and stakeholders to tune in and get the latest updates directly from the source.
How to Access the Call
Participants can join by calling: 1-877-300-8521 (U.S.) or 1-412-317-6026 (International). For those in Israel, the call can be accessed at 1-80-921-2373.
Make sure to use the conference ID: 10203968 to gain entry to the call. There’s also a webcast available where the call will be streamed live. Do check the company website for this streaming options.
About BrainsWay's Technology
As a pioneer in the field, BrainsWay’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) technology significantly enhances mental health treatments. The company's commitment to improving health outcomes is evident through its successful FDA-clearance for several indications based on rigorous clinical studies.
Current Treatment Innovations
The current FDA-approved applications cater to major depressive disorder, which includes alleviating anxiety symptoms or anxious depression, obsessive-compulsive disorder, and smoking addiction. The evidence supporting these treatments is robust, showcasing clinically proven efficacy.
Future Directions and Ongoing Research
BrainsWay is not halting its efforts to innovate. The company is actively engaged in additional clinical trials aimed at various psychiatric, neurological, and addiction disorders. This ongoing research reflects BrainsWay's dedication to shaping the future of mental health care.
Connecting with BrainsWay
Stay Updated on Developments
Investors and interested parties are encouraged to visit BrainsWay’s official website where additional details about the conference call and other relevant company news are provided. Ensuring access at least 10 minutes prior to the call will allow ample time for registration.
Contact Information
If you have questions or need further clarification, feel free to reach out. BrainsWay’s Chief Financial Officer, Ido Marom, is readily available via email at Ido.Marom@BrainsWay.com. For investor inquiries, Brian Ritchie from LifeSci Advisors can be contacted at britchie@lifesciadvisors.com.
Frequently Asked Questions
1. What is the purpose of the upcoming conference call?
The call aims to update stakeholders on BrainsWay's financial results and operational progress in the mental health sector.
2. When will the financial results be released?
The financial results will be publicly announced before the U.S. markets open on the specified date in November.
3. How can I participate in the conference call?
Call in using the provided U.S. or international numbers and use the designated conference ID.
4. What technologies is BrainsWay known for?
BrainsWay is recognized for its Deep TMS™ technology, which offers noninvasive treatments for various mental health disorders.
5. How can I find more about BrainsWay's developments?
Visit BrainsWay’s official website for the latest updates and information about their ongoing projects and results.
